Literature DB >> 9650566

Fasting/re-feeding before initiation enhances the growth of aberrant crypt foci induced by azoxymethane in rat colon and rectum.

F Premoselli1, E Sesca, V Binasco, G Caderni, L Tessitore.   

Abstract

In contrast to the protective effect of chronic caloric restriction on tumor development, we have shown that fasting sustained tumor initiation in rat liver by a noninitiating dose of diethylnitrosamine. Here we investigated whether fasting had a similar favorable effect on initiation in the colorectal mucosa in 80 male F344 rats. Animals fasted for 4 days were given a single s.c. dose of azoxymethane (AOM) (20 mg/kg) on the first day of re-feeding, and rates of kinetic proliferative parameters, and development of the pre-neoplastic lesions such as aberrant crypt foci (ACF), were evaluated. Starvation before AOM treatment enhanced the growth of ACF, as shown by the significantly higher crypt multiplicity of fasted/re-fed rats as compared with fully fed rats (3.97 +/- 0.50 vs. 2.64 +/- 0.20, p < or = 0.025). This difference was associated with perturbations in cell death and cell proliferation. Fasting induced apoptosis and depressed cell division, while re-feeding had opposite effects, resulting in a higher percentage of S-phase cells at the time of AOM injection and 2 days thereafter. Starvation-induced apoptosis may represent the mitogenic stimulus to an increase in the number of cells susceptible to AOM damage, and may favor its fixation, leading to enhanced growth of ACF. Our data therefore suggest that fasting/re-feeding enhances colon cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650566     DOI: 10.1002/(sici)1097-0215(19980717)77:2<286::aid-ijc19>3.0.co;2-9

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Protective effects of short-term dietary restriction in surgical stress and chemotherapy.

Authors:  Sebastian Brandhorst; Eylul Harputlugil; James R Mitchell; Valter D Longo
Journal:  Ageing Res Rev       Date:  2017-02-20       Impact factor: 10.895

Review 2.  Fasting and fasting-mimicking diets for chemotherapy augmentation.

Authors:  Sebastian Brandhorst
Journal:  Geroscience       Date:  2021-01-07       Impact factor: 7.713

Review 3.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

Review 4.  Fasting and Caloric Restriction in Cancer Prevention and Treatment.

Authors:  Sebastian Brandhorst; Valter D Longo
Journal:  Recent Results Cancer Res       Date:  2016

Review 5.  Fasting and cancer: molecular mechanisms and clinical application.

Authors:  Alessio Nencioni; Irene Caffa; Salvatore Cortellino; Valter D Longo
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

6.  Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy.

Authors:  Changhan Lee; Lizzia Raffaghello; Sebastian Brandhorst; Fernando M Safdie; Giovanna Bianchi; Alejandro Martin-Montalvo; Vito Pistoia; Min Wei; Saewon Hwang; Annalisa Merlino; Laura Emionite; Rafael de Cabo; Valter D Longo
Journal:  Sci Transl Med       Date:  2012-02-08       Impact factor: 17.956

7.  Get the fat out!

Authors:  Natalia A Ignatenko; Eugene W Gerner
Journal:  Cancer Prev Res (Phila)       Date:  2013-03

Review 8.  Dietary restriction: could it be considered as speed bump on tumor progression road?

Authors:  Antonina Cangemi; Daniele Fanale; Gaetana Rinaldi; Viviana Bazan; Antonio Galvano; Alessandro Perez; Nadia Barraco; Daniela Massihnia; Marta Castiglia; Salvatore Vieni; Giuseppe Bronte; Mario Mirisola; Antonio Russo
Journal:  Tumour Biol       Date:  2016-04-04

Review 9.  Energy Restriction and Colorectal Cancer: A Call for Additional Research.

Authors:  Maria Castejón; Adrian Plaza; Jorge Martinez-Romero; Pablo Jose Fernandez-Marcos; Rafael de Cabo; Alberto Diaz-Ruiz
Journal:  Nutrients       Date:  2020-01-01       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.